Related Experiment Videos
[Resection for lung cancer invading the superior vena cava]
Zhong-min Peng1, Jing-han Chen, Long Meng
1Department of Thoracic Surgery, Shandong Provincial Hospital, Jinan 250021, China. pengzhm@163.com
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|April 28, 2006
Summary
Resection of lung cancer invading the superior vena cava (SVC) is feasible in selected patients, particularly those with localized nodal disease. Induction chemotherapy improves survival outcomes for these patients.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Pulmonary Medicine
Context:
- Lung cancer invasion of the superior vena cava (SVC) presents complex surgical challenges.
- Evaluating the efficacy of surgical resection for SVC-involved lung cancer is crucial for treatment planning.
Purpose:
- To assess the feasibility and value of surgical resection for lung cancer invading the SVC.
- To analyze survival rates and identify factors influencing outcomes in patients undergoing SVC resection.
Summary:
- Retrospective analysis of 31 patients undergoing SVC resection for lung cancer between 1988-2005.
- Reconstruction methods included simple suture, pericardial patch, or prosthetic replacement.
- One, three, and five-year survival rates were 61%, 33%, and 21%, respectively. Survival was significantly better for patients with localized nodal disease (N0/N1) and those receiving induction chemotherapy.
Impact:
- Surgical resection of the SVC for lung cancer is viable in carefully selected patients.
- Induction chemotherapy is recommended to improve survival in patients with lung cancer invading the SVC.
- Outcomes are significantly influenced by nodal status, highlighting the importance of staging in treatment decisions.